AS a marathon runner and someone who’d never smoked, Warren Gray wasn’t worried when he developed what he thought was an ...

Alecensa (alectinib) is now an option for patients with stage 1b to 3a ALK-positive NSCLC who have ... In another positive development for the lung cancer community, NICE has also given its ...

When she first experienced occasional chest pain and breathlessness, she brushed it off as stress or fatigue. However, as the ...

Early-stage lung cancer usually refers to stages 1, 2, and 3A non-small cell lung cancer (NSCLC) as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early stages ...

Comparatively, stage 2b and stage 3a lung cancers have similar features and treatment approaches, as do stage 3b and stage 4a lung cancers. To better address the wide variability of lung cancer in all ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new ...

Roche’s plan to bolster Tecentriq’s position in small cell lung cancer with Jazz Pharmaceuticals’ Zepzelca has paid off. | ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...